Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Qing Wei, Guoman Liu, Zihua Huang, Yanyan Huang, Lizheng Huang, Zheng Huang, Xianjian Wu, Huamei Wei & Jian Pu. (2023) LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1019-1035.
Read now
Read now
Articles from other publishers (11)
Xuejiao Leng, Mengyuan Zhang, Yujing Xu, Jingjing Wang, Ning Ding, Yancheng Yu, Shanliang Sun, Weichen Dai, Xin Xue, Nianguang Li, Ye Yang & Zhihao Shi. (2024) Non-coding RNAs as therapeutic targets in cancer and its clinical application. Journal of Pharmaceutical Analysis.
Crossref
Crossref
Qian LiuChunfu ZhuYanfen Dong. (2023)
LncRNA TCTN2 Promotes the Malignant Development of Hepatocellular
Carcinoma
via
Regulating mIR-1285-3p/ARF6 Axis
. Recent Patents on Anti-Cancer Drug Discovery 18:4, pages 517-527.
Crossref
Crossref
Yabing Hu, Yongchu Huang, Xiaohang Xie, Longshan Li, Yong Zhang & Xiaochao Zhang. (2023) ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling. Cancer Cell International 23:1.
Crossref
Crossref
Beatriz Almeida, Tânia Dias, Ana Teixeira, Francisca Dias & Rui Medeiros. (2023) MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?. Cancers 15:16, pages 4017.
Crossref
Crossref
Qing Lu, Hongze Che, Yanhai Che & Min Hu. (2023) CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p. Clinical and Translational Oncology 25:6, pages 1690-1701.
Crossref
Crossref
Eman A. Toraih, Manal S. Fawzy, Bo Ning, Mourad Zerfaoui, Youssef Errami, Emmanuelle M. Ruiz, Mohammad H. Hussein, Muhib Haidari, Melyssa Bratton, Giovane G. Tortelote, Sylvia Hilliard, Naris Nilubol, Jonathon O. Russell, Mohamed A. Shama, Samir S. El-Dahr, Krzysztof Moroz, Tony Hu & Emad Kandil. (2022) A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence. Cancers 14:17, pages 4128.
Crossref
Crossref
Warren B. Nothnick. (2022) MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology. Cells 11:7, pages 1096.
Crossref
Crossref
Sepideh Kadkhoda & Soudeh Ghafouri-Fard. (2022) Function of miRNA-145–5p in the pathogenesis of human disorders. Pathology - Research and Practice 231, pages 153780.
Crossref
Crossref
Linpei Wang, Xiaoqiu Ma, Youqi Chen, Jiahui Zhang, Jiawei Zhang, Wei Wang & Shaojian Chen. (2022) MiR-145-5p Suppresses Hepatocellular Carcinoma Progression by Targeting ABHD17C. Oncologie 24:4, pages 897-912.
Crossref
Crossref
Roberta Resaz, Davide Cangelosi, Daniela Segalerba, Martina Morini, Paolo Uva, Maria Carla Bosco, Giuseppe Banderali, Ana Estrella, Corbinian Wanner, David A. Weinstein, Annalisa Sechi, Sabrina Paci, Daniela Melis, Maja Di Rocco, Young Mok Lee & Alessandra Eva. (2021) Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients. International Journal of Molecular Sciences 23:1, pages 328.
Crossref
Crossref
Xin Chen, Zhenyao Chen, Hao Wu, Xianghua Liu, Fengqi Nie, Zhaoxia Wang & Ming Sun. (2021) Comprehensive Genomic Characterization Analysis Identifies an Oncogenic Pseudogene RP11-3543B.1 in Human Gastric Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref